Abstract #1002

Reduced Cerebral GABA in Patients with Amnestic Mild Cognitive Impairment (AMCI) May Predict Progression to Alzheimers Disease (AD)

Napapon Sailasuta¹, Kent Harris¹, Ralph Noeske²

¹HMRI, Pasadena, CA, United States; ²Research and Collaboration, GE Healthcare, Berlin, Germany

We report GABA concentration is reduced in amnestic mild cognitive impaired subjects and proposed that GABA can be used as marker for AD.